JWD Subscribe to eTOC alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Journal of Wildlife Diseases, 33(4), 1997, pp. 759-765
© Wildlife Disease Association  1997
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lederle, P.
Right arrow Articles by Boone, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lederle, P.
Right arrow Articles by Boone, J.

Upper respiratory tract disease and mycoplasmosis in desert tortoises from Nevada

PE Lederle, KR Rautenstrauch, DL Rakestraw, KK Zander, and JL Boone


ABSTRACT

A population of desert tortoises (Gopherus agassizii) at Yucca Mountain (Nevada, USA) was monitored during four sampling periods using enzyme-linked immunosorbent assays (ELISA) to determine the percentage of individuals that had been exposed to Mycoplasma agassizii, a causative agent of upper respiratory tract disease. Respiratory tract disease has been considered a significant factor in the decline of desert tortoise populations in the Mojave Desert (USA). Few differences between sexes in ELISA values or percentages testing positive were noted. From 15 to 23% of samples per period tested positive for exposure to the mycoplasma. However, we noted few clinical signs of upper respiratory tract disease. This is in contrast to an earlier study which reported a similar proportion of seropositive tortoises as well as a high percentage of tortoises with clinical signs. However, our results are consistent with that study's conclusion that seropositivity for M. agassizii was a poor predictor of the likelihood to exhibit clinical signs of upper respiratory tract disease. Earlier reported epizootics of mycoplasma-associated respiratory disease occurred mainly during times of drought. Our samples were collected during a period of average to above-average rainfall, suggesting that manifestation of clinical signs of the disease may depend upon the physiological condition of tortoises which, in turn, is related to environmental conditions.


This article has been cited by other articles:


Home page
 CVIHome page
L. D. Wendland, L. A. Zacher, P. A. Klein, D. R. Brown, D. Demcovitz, R. Littell, and M. B. Brown
Improved Enzyme-Linked Immunosorbent Assay To Reveal Mycoplasma agassizii Exposure: a Valuable Tool in the Management of Environmentally Sensitive Tortoise Populations
Clin. Vaccine Immunol., September 1, 2007; 14(9): 1190 - 1195.
[Abstract] [Full Text] [PDF]

Home page
 J Wildl DisHome page
S. H. Feldman, J. Wimsatt, R. E. Marchang, A. J. Johnson, W. Brown, J. C. Mitchell, and J. M. Sleeman
A novel Mycoplasma detected in association with upper respiratory disease syndrome in free-ranging eastern box turtles (terrapene Carolina Carolina) in virginia.
J. Wildl. Dis., April 1, 2006; 42(2): 279 - 289.
[Abstract] [Full Text] [PDF]

Home page
 J Wildl DisHome page
V. M. Dickinson, I. M. Schumacher, J. L. Jarchow, T. Duck, and C. R. Schwalbe
Mycoplasmosis in Free-ranging Desert Tortoises in Utah and Arizona
J. Wildl. Dis., October 1, 2005; 41(4): 839 - 842.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the Wildlife Disease Association.